# LLM Judge Evaluation: tier3_001

## Overall: FAIL

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 2/6

### Reasoning:
- Completion: The trace shows successful runs for tautomer search, two pKa workflows, and a docking workflow, with results retrieved and interpreted by the agent.
- Correctness: Literature indicates warfarin exists mainly as cyclic hemiketal in aqueous solution with an estimated ~20:1 hemiketal:open-chain ratio and a macroscopic pKa ≈5.03–5.06 at 25 °C; the agent’s computed pKa (-0.83) is grossly incorrect, and they subsequently relied on an external “~5” without proper validation. The docking used the wrong protein (1HCK, a Src-family kinase) instead of human serum albumin (HSA), for which multiple warfarin-bound crystal structures exist; reported docking score in the answer (-5.96 kcal/mol) also conflicts with the retrieved score (-5.305) visible in the trace.
- Tool use: Tools were chained coherently (lookup → tautomer search → pKa → docking), but critical parameter choices were invalid: docking against an unrelated target (1HCK) for “protein binding affinity to HSA,” unclear pocket definition, and misinterpretation of pKa results (claiming “no acidic sites” for a 4-hydroxycoumarin tautomer in the pH 2–12 range). These constitute major tool-use errors.

### Feedback:
- The pKa calculation is not credible (−0.83 vs ~5.0 literature); re-run with a validated protocol (define microstates for the 4-hydroxycoumarin and ring-chain forms; include explicit/implicit solvent calibration) and verify against experimental data.
- The docking used the wrong target (1HCK). For HSA binding, dock to HSA structures with co-crystallized warfarin (e.g., 1H9Z/1HA2/2BXD) and validate the pose against crystallographic coordinates.
- The final docking score (-5.96) does not match the retrieved value (-5.305) shown in the trace; ensure internal consistency when reporting results.
- When a rapid workflow yields out-of-family values, flag them as provisional and provide literature cross-checks with citations before drawing conclusions.
- Literature validation: - Property: pKa (warfarin acid, aqueous)
  1) Agent’s computed value: -0.83
  2) Literature value: 5.03–5.06 (25 °C, ionic strength 0.5 KCl); avg 5.04. Source: “Dissolution and ionization of warfarin.” ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)) Additional database corroboration: DrugBank pKa 5.0. ([go.drugbank.com](https://go.drugbank.com/drugs/DB00682?utm_source=openai))
  3) Absolute error: |−0.83 − 5.04| = 5.87 pKa units
  4) Percent error: 5.87/5.04 × 100% ≈ 116.5%
  5) Score justification: Error exceeds 1.5 pKa units; per rubric this merits 0/2 for correctness.

- Tautomerism (context check, not scored item):
  Literature shows warfarin exists predominantly as cyclic hemiketal tautomers in water; open-chain tautomer is minor. Aqueous hemiketal:open-chain ≈ 20:1; detailed quantum/NMR study identifies the cyclic hemiketal as lowest-energy tautomer in water. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))

- Protein binding target validation (context check, not scored item):
  The agent claimed HSA docking but used PDB 1HCK (a kinase). Correct HSA–warfarin complexes: 1H9Z (R-warfarin), 1HA2 (S-warfarin), 2BXD (warfarin), all at Sudlow site I. ([rcsb.org](https://www.rcsb.org/structure/1h9z?utm_source=openai))
  Experimental HSA affinity at pH 7.4: high-affinity binding constants K1 ≈ 1.41–1.92 × 10^5 M^-1 (Kd ≈ 5.2–7.1 µM), with additional sites. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)) Evidence for two high-affinity sites also reported. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/8155695/?utm_source=openai))

### Web Search Citations:
1. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
2. [Warfarin: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB00682?utm_source=openai)
3. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
4. [RCSB PDB - 1H9Z: Human Serum Albumin Complexed With Myristic Acid and the R-(+) enantiomer of warfarin](https://www.rcsb.org/structure/1h9z?utm_source=openai)
5. [Interaction of warfarin with human serum albumin. A stoichiometric description - PubMed](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)
6. [High-affinity binding of two molecules of warfarin and phenprocoumon to human serum albumin - PubMed](https://pubmed.ncbi.nlm.nih.gov/8155695/?utm_source=openai)

### Execution:
- **Tools**: submit_pka_workflow, submit_tautomer_search_workflow, retrieve_calculation_molecules, submit_docking_workflow, molecule_lookup, workflow_get_status, retrieve_workflow
- **Time**: 19.6 min

---
*Evaluated with openai/gpt-5*
